Mei‐Juan Tu

Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression

Xin Li, Ye Tian, Mei‐Juan Tu et al. · Acta Pharmaceutica Sinica B · 2018 · 70 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy

Pui Yan Ho, Zhijian Duan, Neelu Batra et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 68 citations · Full text

Life Sciences, Biological Engineering, Biotechnology +8

A reliable LC-MS/MS method for the quantification of natural amino acids in mouse plasma: Method validation and application to a study on amino acid dynamics during hepatocellular carcinoma progression

Zhenzhen Liu, Mei‐Juan Tu, Chao Zhang et al. · Journal of Chromatography B · 2019 · 67 citations · Full text

Pharmacy, Biochemistry, Pharmacokinetics +17

Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics

Wanrong Yi, Mei‐Juan Tu, Zhenzhen Liu et al. · Acta Pharmaceutica Sinica B · 2019 · 67 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth

Yong Zhao, Mei‐Juan Tu, Yi-Feng Yu et al. · Biochemical Pharmacology · 2015 · 64 citations

Medicine, Oncology, Pharmacology +11